Dedifferentiation of cardiomyocytes into cardiac progenitor cells

心肌细胞去分化为心脏祖细胞

• 批准号: 8436173
• 负责人: EDUARDO MARBAN
• 金额: $ 39.75万
• 依托单位: CEDARS-SINAI MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-01 至 2015-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8436173
• 关键词: ABCG2 gene; Address; Adult; Antigens; Biological; CD15 Antigens; Cardiac; Cardiac Myocytes; Cell Culture Techniques; Cell Cycle; Cell Cycle Proteins; Cell physiology; Cells; Conditioned Culture Media; Coupling; Data; Development; Educational process of instructing; Embryo; Embryonic Development; Gene Expression; Generations; Genetic; Grant; Heart; Heart Diseases; In Situ; In Vitro; Infarction; Injury; Life; Maps; MicroRNAs; Molecular; Mus; Muscle Cells; Myocardial; Myocardial Infarction; Myocardium; Natural regeneration; Neonatal; Organ; Phenotype; Physicians; Process; Progress Reports; Proliferating; Proto-Oncogene Protein c-kit; Seeds; Smooth Muscle Myocytes; Stem cells; Testing; Therapeutic; Transcript; Vascular Endothelial Cell; Work; Zebrafish; autocrine; heart cell; improved; improved functioning; in vivo; injured; paracrine; postnatal; precursor cell; progenitor; programs; public health relevance; reconstitution; repaired; response to injury; self-renewal; stem; stemness; transdifferentiation

DESCRIPTION (provided by applicant): Cardiac progenitor cells (CPCs) in the adult mammalian heart are identified by stem cell-related antigens, multipotency, and by their ability to regenerate myocardium endogenously and iatrogenically. CPCs, when injected into the heart after ischemic injury, produce limited multilineage differentiation (cardiomyocytes, endothelial cells, vascular smooth muscle cells) and functional benefits. The origin of CPCs is as-yet unclear. Some if not most CPCs are likely of innate embryonic origin within the heart; exogenous bloodborne precursor cells can also seed the heart after injury. Another potential mechanism of origin that has been overlooked is that of dedifferentiation, a process whereby mature, specialized cells regain proliferative ability and augmented plasticity. The established paradigm for cardiomyocyte development posits a one-way transit from precursor cells through neonatal cardiomyocytes on to mature heart cells, which can no longer divide and proliferate. Adult zebrafish cardiomyocytes, in contrast, re-enter the cell cycle with alacrity, but even they have not been demonstrated to dedifferentiate to a state of multipotency. The major discovery in the initial grant period of this R01 was the recognition of the ability of postnatal mammalian cardiomyocytes to dedifferentiate and acquire features of CPCs. Preliminary data supporting this claim are presented in the progress report. The proposed ability of dedifferentiated cardiomyocytes to become CPCs, if verified by the work proposed here, would change fundamentally our view of the adult heart and its potential plasticity. For this reason, we seek to demonstrate cardiomyocyte dedifferentiation to CPCs by multiple complementary experimental approaches; to characterize the underlying molecular and cellular mechanisms; and to establish the pathophysiological relevance of dedifferentiation. We will test the idea that cell culture promotes dedifferentiation, cell cycle re- entry, and acquisition of "stemness". Genetic cell fate mapping will be utilized to establish that confirmed cardiomyocytes dedifferentiate, express c-kit, and are capable of differentiating into at least two cardiac lineages. Specific questions to be addressed include: How often and under what conditions do dedifferentiating cardiomyocytes re-enter the cell cycle? What changes in gene expression, microRNAs, and cell cycle regulatory proteins underlie the dedifferentiation process? Are autocrine/paracrine factors in conditioned media important in cardiomyocyte dedifferentiation? Do dedifferentiated cardiomyocytes express stem cell antigens? Are they pluripotent? Can they be clonally proliferated? Can dedifferentiated cardiomyocytes re-differentiate and transdifferentiate in vitro? When injected into injured hearts, do dedifferentiated cardiomyocytes engraft, differentiate and improve function? Do genetically-defined cardiomyocytes dedifferentiate in situ in response to injury? Does endogenous myocardial regeneration after infarction reflect dedifferentiation and subsequent multilineage differentiation of cardiomyocytes? The work tests the idea that CPCs may arise from dedifferentiation as well as embryogenesis or bloodborne seeding.

描述（由申请人提供）：成年哺乳动物心脏中的心脏祖细胞（CPC）通过干细胞相关抗原、多能性及其内源性和医源性心肌再生能力进行鉴定。CPC在缺血性损伤后注射到心脏中时，产生有限的多谱系分化（心肌细胞、内皮细胞、血管平滑肌细胞）和功能益处。CPC的起源至今尚不清楚。如果不是大多数CPC，也有一些可能是心脏内的先天胚胎起源;外源性血源性前体细胞也可以在损伤后接种心脏。另一个被忽视的潜在起源机制是去分化，这是一个成熟的特化细胞恢复增殖能力和增强可塑性的过程。心肌细胞发育的既定模式假定从前体细胞通过新生心肌细胞到成熟心脏细胞的单向过渡，成熟心脏细胞不再能够分裂和增殖。相反，成年斑马鱼的心肌细胞很快就重新进入细胞周期，但即使是它们也没有被证明去分化成多能性状态。在R 01的初始授权期间的主要发现是认识到出生后哺乳动物心肌细胞去分化和获得CPC特征的能力。进度报告提供了支持这一索赔的初步数据。去分化的心肌细胞成为CPC的能力，如果通过这里提出的工作得到验证，将从根本上改变我们对成人心脏及其潜在可塑性的看法。出于这个原因，我们试图通过多种互补的实验方法来证明心肌细胞去分化为CPC;表征潜在的分子和细胞机制;并建立去分化的病理生理学相关性。我们将检验细胞培养促进去分化、细胞周期再进入和获得“干性”的观点。基因细胞命运图谱将用于确定确认的心肌细胞去分化，表达c-kit，并且能够分化成至少两种心脏谱系。需要解决的具体问题包括：去分化心肌细胞重新进入细胞周期的频率和条件是什么？去分化过程中基因表达、microRNA和细胞周期调控蛋白的变化是什么？条件培养液中的自分泌/旁分泌因子在心肌细胞去分化中是否重要？去分化心肌细胞表达干细胞抗原吗？它们是多能性的吗？它们能克隆繁殖吗？去分化心肌细胞能否在体外再分化和转分化？当注射到受损的心脏时，去分化的心肌细胞是否能移植、分化并改善功能？基因定义的心肌细胞在损伤后原位去分化吗？梗死后内源性心肌再生是否反映了心肌细胞的去分化和随后的多向分化？这项工作测试的想法，CPCs可能产生的去分化，以及胚胎发生或血源性播种。